JN Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

J Neurophysiol (June 7, 2006). doi:10.1152/jn.01313.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
96/3/1053    most recent
01313.2005v2
01313.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parnas, I.
Right arrow Articles by Parnas, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parnas, I.
Right arrow Articles by Parnas, H.
Submitted on December 14, 2005
Accepted on May 20, 2006

The Role of NSF in Neurotransmitter Release: A Peptide Microinjection Study at the Crayfish Neuromuscular Junction

Itzchak Parnas1*, Grigory Rashkovan1, Vincent O'Connor2, Ossama El-Far3, Heinrich Betz4, and Hanna Parnas1

1 Neurobiology, Hebrew University, Jerusalem, Israel
2 Cell Sciences, University of Southampton, Southampton, United Kingdom
3 Faculty of Medicine, INSERM, Marseille, France
4 Max-Planck Institute for Brain Research, Frankfurt, Germany

* To whom correspondence should be addressed. E-mail: parnas{at}huji.ac.il.

Peptides that inhibit the SNAP-stimulated ATPase activity of NSF (NSF-2, NSF-3) were injected intra-axonally to study the role of this protein in the release of glutamate at the crayfish neuromuscular junction. Macropatch recording was used to establish the quantal content and to construct synaptic delay histograms. NSF-2 or NSF-3 injection reduced the quantal content, evoked by either direct depolarization of a single release bouton or by axonal action potentials, on average by 66±12% (n=32), but had no effect on the time course of release. NSF-2 had no effect on the amplitude or shape of the presynaptic action potential nor on the excitatory nerve terminal current. Both NSF-2 and NSF-3 did not affect the shape or amplitude of single quantal currents. Injection of a peptide with the same composition as NSF-2, but with a scrambled amino acid sequence failed to alter the quantal content. We conclude that, at the crayfish neuromuscular junction, NSF-dependent reactions regulate quantal content without contributing to the presynaptic mechanisms that control the time course of release.




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. M. Kupchik, G. Rashkovan, L. Ohana, T. Keren-Raifman, N. Dascal, H. Parnas, and I. Parnas
Molecular mechanisms that control initiation and termination of physiological depolarization-evoked transmitter release
PNAS, March 18, 2008; 105(11): 4435 - 4440.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. Kuner, Y. Li, K. R. Gee, L. F. Bonewald, and G. J. Augustine
Photolysis of a caged peptide reveals rapid action of N-ethylmaleimide sensitive factor before neurotransmitter release
PNAS, January 8, 2008; 105(1): 347 - 352.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2006 by the The American Physiological Society.